Business
Ventripoint Announces Appointment to the Board of Directors and Option Grants
(TheNewswire) Toronto, Ontario - TheNewswire - September 30, 2020...
About this update from Ventripoint Diagnostics Ltd.
[{"type":"text","content":"Ventripoint Announces Appointment to the Board of Directors and Option Grants\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n Toronto, Ontario -\n \n \n TheNewswire -\n \n \n September 30, 2020\n \n \n -\nVentripoint Diagnostics Ltd.\n \n \n (\"\n \n \n Ventripoint\n \n \n \" or\nthe \"\n \n \n Corporation\n \n \n \"\n \n \n )\n \n \n ,\n \n \n (\n \n \n TSXV:VPT\n \n \n )\n \n \n &\n \n \n (\n \n \n OTC:VPTDF) is\n \n \n pleased to announce, Mr. Hugh MacNaught has been\nappointed as a Director of the Corporation.\n \n \n \n \n Mr. MacNaught is a seasoned life science executive with\nmore than thirty years of experience in the development,\ncommercialization and financing of therapeutic, diagnostic and medical\ndevice technologies and ventures. His career includes roles within\nmultinational corporations including Nordion, Kodak, Boehringer\nMannheim (Roche) and Philips and the venture capital industry. A\nserial entrepreneur, he has founded, financed and led several ventures\nand is a mentor in the entrepreneurship programs at Simon Fraser\nUniversity and the University of British Columbia. He brings strong\nbusiness acumen, governance experience and an extensive network of\nworld-class industry experts to drive transformation of\ntechnology-based ventures.\n \n \n \n \n \"I am pleased to join the Board of\nVentripoint\" said Mr. MacNaught. \"The Company's heart\nanalysis system provides important functionality to cardiac ultrasound\nand equips cardiologists with the ability to more efficiently assess\nand manage patients,\n \n \n whose outcomes could be\nimproved with better access to highly accurate and timely 3D whole\nheart analysis\n \n \n . The Ventripoint team has done an\nexcellent job in evolving the VMS technology into an attractive\nproduct offering. I look forward to working with the board and\nmanagement to accelerate the placement of systems into leading cardiac\ncentres in the U.S., Europe, and Canada\".\n \n \n \n \n \"The Corporation welcomes Hugh to the Board of\nDirectors and looks forward to his assistance in building value for\nthe shareholders of the Corporation,\" stated Dr. George Adams,\nVentripoint's Executive-Chairman. \"Expanding the Board is\nappropriate at this time as the Corporation resumes deliveries of\nVMS+3.0 whole-heart analysis systems.\"\n \n \n \n \n The Corporation has award...